Infusion operations

Infusion center shortage alerts without the daily page chase.

FormularySignal monitors public FDA/openFDA shortage records for your infusion-related watch terms and sends timestamped Signal Cards for internal review.

Public-source checks

Daily scheduled monitoring of public FDA/openFDA shortage records.

Watchlist matching

Match against organization-level terms such as drug names, manufacturers, categories, or NDCs.

Internal review

Alerts are timestamped and source-linked so your team can verify public records before acting internally.

The infusion-center workflow

Infusion teams often monitor sterile injectables, oncology-related therapies, supportive-care terms, manufacturers, and categories that affect scheduling conversations and internal review. FormularySignal does not decide what to administer or buy; it keeps the public-record check from depending on memory.

  • Use organization-level watch terms such as carboplatin, cisplatin, dexamethasone, sodium chloride, sterile injectable, manufacturer names, or NDCs.
  • Route Signal Cards to the person who already checks public shortage pages.
  • Verify source links before internal operations, pharmacy, or scheduling review.

Boundary

Public national-source monitoring only. Local availability may differ. FormularySignal is not FDA-affiliated, does not accept PHI, and does not provide clinical, substitution, procurement, inventory, compounding, dispensing, scheduling, or treatment advice.